Group 1: Company Overview - Dapeng Industrial is a leading manufacturer of specialized intelligent equipment for industrial precision cleaning, primarily serving the automotive and new energy sectors [2][3] - The company is actively expanding into machine vision detection products to address identified gaps in the market, leveraging its existing technology and market resources [3] - Dapeng Industrial has established long-term partnerships with major automotive manufacturers, including BYD, Changan, and Geely, among others [3] Group 2: Financial Performance - Dapeng Industrial's accounts receivable from 2022 to mid-2025 were reported as 89.63 million, 83.68 million, 130.99 million, and 109.95 million respectively, indicating a significant amount of receivables relative to sales [4] - The company warns that economic downturns or adverse changes in client creditworthiness could extend the collection period for accounts receivable, impacting cash flow and operations [4] Group 3: Market Position and Products - Fengbei Bio, established in 2014, focuses on the comprehensive utilization of waste oil resources, with a secondary business in oil chemical products [5] - The company has achieved a market share of approximately 4.68% in the biodiesel sector, ranking sixth in production capacity in China [6] - Fengbei Bio's revenue from waste oil resource utilization consistently accounts for over 75% of its total income, highlighting its core business focus [7] Group 4: Innovation and Patents - Fengbei Bio has secured 135 patents, including 33 domestic invention patents and 3 international invention patents, showcasing its commitment to innovation [5] - The company has established research centers to enhance its technological capabilities in oil processing and utilization [5] Group 5: Risks and Challenges - Fengbei Bio faces potential supply constraints if it fails to establish timely partnerships with waste oil recovery enterprises, which could adversely affect its operations [7] - The company also cautions that significant increases in waste oil procurement prices could impact its profitability if product prices cannot be adjusted accordingly [7]

Group 1: Dapeng Industrial (920091.BJ) - Dapeng Industrial is a leading manufacturer of specialized intelligent equipment for industrial precision cleaning, primarily serving the automotive and new energy sectors [2][4] - The company aims to leverage its existing technology and market resources to expand into machine vision detection products, creating a second growth curve [2][4] - The initial public offering (IPO) price is set at 9.00 CNY per share, with a projected market capitalization yet to be disclosed [3] - The company has established long-term partnerships with major automotive manufacturers such as BYD, Changan, and Geely, which contributes to its stable customer base [5] - Financial data shows that accounts receivable from 2022 to mid-2025 were 89.63 million CNY, 83.68 million CNY, 130.99 million CNY, and 109.95 million CNY respectively, indicating a significant portion of sales revenue tied up in receivables [5] Group 2: Fengbei Biological (603334.SH) - Fengbei Biological focuses on the comprehensive utilization of waste oil resources, with its main products being bio-based materials and biofuels [6][8] - The IPO price is set at 24.49 CNY per share, with a market capitalization of 3.514 billion CNY [7] - The company has achieved significant growth in revenue, with figures of 1.709 billion CNY, 1.728 billion CNY, and 1.948 billion CNY for 2022 to 2024, reflecting year-on-year growth rates of 31.89%, 1.12%, and 12.75% respectively [9] - Fengbei has established a strong customer base, including global trading firms like TRAFIGURA and CARGILL, enhancing its market position [8] - The company holds 135 patents, including 33 domestic invention patents, indicating a strong focus on innovation [8]

Core Viewpoint - The news discusses the IPO of two companies: Dapeng Industrial, a leading manufacturer in the industrial precision cleaning sector, and Fengbei Bio, which focuses on waste oil resource utilization. Both companies are positioned to capitalize on their respective market trends and technological advancements [1][6]. Dapeng Industrial - Dapeng Industrial specializes in intelligent equipment for industrial precision cleaning, primarily serving the automotive sector, including traditional and new energy vehicles [2][4]. - The company aims to expand its product line into machine vision detection systems, addressing gaps in defect detection and recognition accuracy in large industrial components [4]. - Dapeng Industrial has established long-term partnerships with major automotive manufacturers, including BYD, Changan, and Geely, which enhances its market position [5]. - Financially, Dapeng Industrial's accounts receivable from 2022 to mid-2025 show amounts of 89.63 million, 83.68 million, 130.99 million, and 109.95 million yuan, indicating a significant proportion of sales revenue tied up in receivables [5]. Fengbei Bio - Fengbei Bio, established in 2014, focuses on the comprehensive utilization of waste oil resources, producing bio-based materials and biofuels [6][8]. - The company has secured 135 patents, including 33 domestic invention patents, and has been recognized as a national-level "little giant" enterprise [6]. - Fengbei Bio's market share in the domestic pesticide adjuvant and fertilizer adjuvant sectors is approximately 6.72% and 6.46%, respectively, indicating a solid position in the agricultural chemical market [7][8]. - The company's revenue from 2022 to 2024 is projected to be 1.709 billion, 1.728 billion, and 1.948 billion yuan, with growth rates of 31.89%, 1.12%, and 12.75% respectively [8].

Core Viewpoint - The company aims to leverage capital markets to broaden financing channels, attract top talent, and enhance corporate governance, with a vision to become a leading enterprise in the comprehensive utilization of global oil resources, while ensuring sustainable development and social responsibility [2][9]. Company Overview - Fengbei Bio is a large-scale enterprise in the field of waste oil resource utilization in China, with a competitive advantage in the depth and breadth of waste oil resource utilization compared to peers [4]. - The company is one of the few in China capable of producing industrial-grade mixed oil products that meet the requirements for Sustainable Aviation Fuel (SAF) [4]. Market Position - Fengbei Bio's pesticide adjuvant revenue ranks among the top five in China, with its biodiesel-based pesticide adjuvants holding the largest market share domestically [5]. Environmental Impact - The company’s efforts in waste oil resource utilization contribute to reducing the risk of "gutter oil" re-entering the food chain and promote the development of a circular economy [6]. - The main products from waste oil resource utilization are bio-based materials and biofuels, which are categorized as strategic emerging industries and are encouraged by national policies [6]. Technological Innovation - Fengbei Bio has been recognized as a national-level "specialized, refined, and innovative" small giant enterprise, indicating its strong capabilities in technology and innovation [7]. - The company has established a comprehensive industrial chain for waste oil resource regeneration, enabling it to continuously iterate product applications and convert waste oil into high-value resources [8]. IPO and Future Plans - The funds raised from the IPO will be invested in projects aimed at expanding the waste resource regeneration industrial chain, aligning with domestic and international circular economy requirements [9]. - The company plans to invest more resources in technology research and development, product iteration, and industrial chain upgrades to foster industry resonance and deep collaboration [9].

股票简称：丰倍生物 股票代码：603334 苏州丰倍生物科技股份有限公司 SUZHOU FENGBEI BIOTECH STOCK CO., LTD. （江苏扬子江国际化学工业园东海路 1 号） 首次公开发行股票主板上市公告书 保荐人（主承销商） （中国（上海）自由贸易试验区商城路 618 号） 二〇二五年十一月四日 苏州丰倍生物科技股份有限公司 上市公告书 特别提示 苏州丰倍生物科技股份有限公司（以下简称"丰倍生物""发行人""本公 司"或"公司"）股票将于 2025 年 11 月 5 日在上海证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在新 股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 本上市公告书中若出现总数与各分项数值之和尾数不等的情况，均为四舍五 入尾差所致。 1 苏州丰倍生物科技股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明与提示 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真实、 准确、完整，承诺上市公告书不存在虚假记载、误导性陈述或者重大遗漏，并依 法承担法律责任。 上海证券交易所、有关政府机关对本公司股票上 ...

苏州丰倍生物科技股份有限公司 保荐人（主承销商）：国泰海通证券股份有限公司 扫描二维码查阅公告全文 本公司及全体董事、高级管理人员保证信息披露的内容真实、准确、完整、 及时，没有虚假记载、误导性陈述或重大遗漏。 经上海证券交易所（以下简称"上交所"）审核同意，苏州丰倍生物科技股 份有限公司（以下简称"丰倍生物""发行人"或"公司"）人民币普通股股票 将于 2025 年 11 月 5 日在上交所主板上市，上市公告书全文和首次公开发行股票 的招股说明书全文披露于上交所网站（http://www.sse.com.cn）和符合中国证券监 督管理委员会规定条件的网站（中国证券网，网址 www.cnstock.com；中证网， 网址 www.cs.com.cn；证券时报网，网址 www.stcn.com；证券日报网，网址 www.zqrb.cn； 经 济 参 考 网 ， 网 址 www.jjckb.cn； 金 融 时 报 ， 网 址 www.financialnews.com.cn；中国日报，网址 www.chinadaily.com.cn），并置备于 发行人、本次发行保荐人（主承销商）国泰海通证券股份有限公司的住所，供 ...

苏州丰倍生物科技援 章 程 (草案) 2025 年 10 月 776 | 第一章 总 则 | | --- | | 第二章 经营宗旨和范围 | | 份 . 第三章 股 | | 股份发行 第一节 | | 第二节 股份增减和回购 | | 第三节 股份转让 . | | 第四章 股东和股东会 - | | 第一节 股 东 | | 第二节 股东会的一般规定 | | 第三节 股东会的召集 . | | 第四节 股东会的提案与通知 . | | 第五节 股东会的召开 | | 第六节 股东会的表决和决议 | | 第五章 董事会 ……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………26 | | 第一节 董 事 | | 第二节 董事会 …………………………………………………………………………………… 31 | | 第六章 高级管理人员 . | | 第七章 财务会计制度、利润分配和审计 . | | 第一节 财务会计制度 . | | 第二节 利润分配 ……………………………… ...